Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Fetal Embolization Of Vein Of Galen Malformation Using Target Xl And Xxl Detachable Coils

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04434729Not ApplicableCompletedPrimary

Fetal Treatment of Galenic Malformations

NCT07483255Not ApplicableRecruitingPrimary

A Phase II Trial of Fetal Embolization for Vein of Galen Malformation

Showing all 2 trials

Research Network

Common Treatments

  • Fetal Embolization Of Vein Of Galen Malformation Using Target Xl And Xxl Detachable Coils2

Active Sponsors

  • Darren Orbach2

Top Investigators

Activity Timeline